Synthesis and Antimicrobial Activity of Some New Coumarin Incorporated Pyridine-3-carbonitrile Derivatives
Journal of Pharmaceutical Research International,
Page 12-20
DOI:
10.9734/jpri/2021/v33i21A31364
Abstract
Drug resistance causes serious difficulties in the routine therapy for curing common microbial infections. Thus it is very essential to develop new antimicrobial agents which can offer alternative treatments. The development of potent and effective antimicrobial agents is of utmost importance to overcome the emerging multidrug resistance strains of bacteria and fungi. The technique involves Knoevenagel reaction between substituted salicylaldehyde and ethyl acetoacetate in presence of piperidine as catalyst to give 3-acetyl coumarin. The intermediate coumarinyl chalcones was synthesized by condensing with various substituted benzaldehyde in presence of ethanolic KOH. The final synthesized pyridine-3-carbonitrile derivative was prepared upon refluxing with coumarinyl chalcones with malononitrile in presence of ammonium acetate. All the newly synthesized compounds were assigned on the basis of IR, 1H NMR and mass spectral data. The finalsynthesized compounds were screened for their antibacterial activity tube dilution method. Most of the compounds showed promising MIC by tube dilution method as compared to standard Cephalosporin.
Keywords:
- Coumarin
- chalcone
- pyridine
- antibacterial activity
How to Cite
References
Dean DA, Burchard KW. Fungal infection in surgical patients. Am J Surg. 1996;171:374–82.
Gonzalez CE, Venzon D, Lee S, Mueller BU, Pizzo PA, Walsh TJ. Risk factors for fungemia in children infected with human immunodeficiency virus: a case-control study.Clin Infect Dis.1996;23:515–21.
Sieradzki K, Wu SW, Tomasz A. Inactivation of the methicillin resistance gene mecA in vancomycin-resistantStaphylococcus aureus.Micro Drug Resist.1999;5(4):253–57.
Crafts KM, Nguyen JM, Berg LJ, Townsend SD. Methicillin-resistant Staphylococcus aureus (MRSA): Antibiotic- resistance and biofilm phenotype. Med Chem Comm. 2019;10:231-41
Hamdi N, Puerta C, Valerga P. Synthesis, structure, antimicrobial and antioxidant investigations of dicoumarol and related compounds. Eur J Med Chem. 2008;43:2541-48.
Ulubelen A, Tpcu, G, Tan N, Olçal S, Johansson C,Uçer M et al. Biological activities of a Turkish medicinal plant, Prangosplatychlaena. J Ethnopharmacol. 1995;45:1930-97.
Ng TB, Ling JM, Wang, ZT, Cai JN, XuGJ.Examination of coumarins, flavonoids and polysaccharopeptide for antibacterial activity. Gen Pharmacol. 1996;27:1237-40.
Murry RDH, Mendez J, Brown SA. The natural coumarins: Occurrence, chemistry and biochemistry. John Wiley and Sons, Chichester; 1982.
Laurin P, Ferroud D, Klich M, Dupuis-Hamelin C, MauvaisP, Lassaigne P et al. Synthesis and in vitro evaluation of novel highly potent coumarin inhibitors of gyrase B. BioorgMedChem. 1999;9:2079-84.
Thaisrivongs S. HIV Protease Inhibitor,s. Annu Rep Med Chem. 1994;29:33-37.
Zhao H, Neamati N, Hong H,Mazumder A, Wang S, SundarSet al. Coumarin-based inhibitors of HIV integrase. J Med Chem. 1997;40:242-49.
Bairagi SH, Salaskar PP, Loke SD, Surve NN, Tandel DV, Dusara MD et al. Medicinal significance of coumarin. Int J Pharm Res.2014;4:16-9.
Fischer MH, Lusi A. Imidazo [1,2-a] pyridine anthelmintic and antifungal agents. J Med Chem. 1972;15:982-85.
Modranka JN, Nawrot E, Graczyk J. In vivo antitumor, in vitro antibacterial activity and alkylating properties of phosphohydrazinederivatives of coumarin and chromone. Eur J Med Chem. 2006;41:1301.
Andrews JN. Determination of minimum inhibitory concentration. J Antimicrob Chemother. 2001;48:5-16.
-
Abstract View: 0 times
PDF Download: 0 times
